NAD+ Booster NMN Restores Egg Quality After Chemotherapy and Aging
NMN supplementation improved oocyte quality in mice with chemotherapy damage and older women, offering hope for fertility preservation.
Summary
Researchers tested nicotinamide mononucleotide (NMN), a NAD+ precursor, on egg quality in mice with chemotherapy-induced ovarian damage and older women. NMN supplementation for 4 weeks restored NAD+ levels, improved mitochondrial function, reduced oxidative stress, and enhanced fertilization rates in damaged mouse eggs. Even 2-week treatment showed benefits. In human studies, NMN improved nuclear competence in eggs from women over 38. The supplement worked by redistributing mitochondria, promoting proper chromosome alignment, and enhancing DNA repair mechanisms.
Detailed Summary
This groundbreaking study addresses a critical challenge facing cancer survivors and older women seeking pregnancy: declining egg quality due to chemotherapy damage and aging. The research offers hope through nicotinamide mononucleotide (NMN), a compound that boosts cellular NAD+ levels.
Researchers used mouse models mimicking different degrees of ovarian damage, from diminished ovarian reserve to premature ovarian insufficiency. They treated mice with NMN in drinking water for either 4 weeks (complete follicle development cycle) or 2 weeks (later stages only), then evaluated egg quality and fertilization success.
The results were remarkable. Four-week NMN treatment restored NAD+ levels, improved mitochondrial distribution for proper chromosome alignment, and recovered fertilization rates in mice with diminished ovarian reserve. In severe damage models, NMN reduced harmful reactive oxygen species, increased mitochondrial quantity, and enhanced DNA repair gene expression. Even shorter 2-week treatments showed significant benefits.
Most importantly, the benefits extended to humans. When researchers treated immature eggs from women over 38 with NMN in laboratory conditions, they observed improved nuclear competence and activation potential compared to younger women's eggs.
These findings suggest NMN could become a valuable tool for fertility preservation in cancer patients and may help older women conceive using their own eggs. However, human clinical trials are needed to confirm safety and effectiveness before clinical application.
Key Findings
- NMN restored NAD+ levels and fertilization rates in chemotherapy-damaged mouse eggs
- Four-week NMN treatment improved mitochondrial function and chromosome alignment
- NMN enhanced DNA repair mechanisms in severely damaged ovarian tissue
- Human eggs from women >38 showed improved nuclear competence with NMN treatment
- Even 2-week NMN supplementation provided measurable oocyte quality benefits
Methodology
Study used mouse models with chemotherapy-induced ovarian damage at different severity levels, comparing 4-week vs 2-week NMN supplementation periods. Human component involved in vitro NMN treatment of immature eggs from women of different ages using germinal vesicle rescue approach.
Study Limitations
Study limited to mouse models and in vitro human egg experiments. No human clinical trials conducted. Long-term safety and optimal dosing protocols remain unknown.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.